pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
910
stories
17d
The main therapy used for children with autism faces changes under Medicaid
stat
17d
Rumors of biggest pharma merger ever drop amid Q2 earnings, contentious FDA adcomms
biospace
17d
Lilly drops another gene therapy trial from $1B Prevail buyout
fiercebiotech
17d
Opinion: Something is missing from movies about medical aid in dying
stat
17d
MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them
stat
17d
5 NextGen winners who went public this year (and which ones are hiring)
biospace
17d
4 potential biotech M&A targets, plus a pretty sure bet from J&J
biospace
17d
Fresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist® Prefilled Syringe Due to Labeling Mix-up
fda medwatch
18d
Pfizer CEO defends $7B bolt-on M&A strategy as peers rush to buy
biospace
18d
Merck plans trial of sac-TMT combo with Keytruda in lung cancer
endpoints
18d
Pfizer expands multibillion-dollar cost-cutting plan
biopharma dive
18d
Merck’s $10.8B Prometheus deal delivers another win—plus a Phase 2b miss
biospace
18d
BioNTech cuts sales forecast on slumping demand for COVID-19 vaccine
biospace
18d
J&J pharma leader to retire; Krystal slumps on gene therapy miss
biopharma dive
18d
Pfizer cuts $2.5B more across R&D, manufacturing in ongoing restructure
biospace
18d
Pathos inks back-to-back cancer contracts with AstraZeneca, China’s Alphamab
biospace
18d
Lisata lays off 72% of staffers, sues Kuva after planned merger falls apart
fiercebiotech
18d
Pfizer axes ex-Metsera obesity asset and GIPR prospect in quarterly clearout
fiercebiotech
18d
Opinion: How Josée became one of the 7.9% of Québécois who die by assisted suicide
stat
18d
Latigo laces up for $247M IPO to fund non-opioid pain drug rival to Vertex’s Journavx
fiercebiotech
18d
Pathos AI pads pipeline with $2.2B Alphamab deal, AstraZeneca pact
fiercebiotech
18d
Recon: Lilly to broaden expanded access for unapproved obesity drug; Jazz to withdraw second-line SCLC indication for Zepzelca
raps
19d
An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.
biopharma dive
19d
BioNTech taps Sobi executive Oelkers as its next CEO
biopharma dive
19d
FDA expands Pluvicto label, making it available to most metastatic prostate cancer patients
endpoints
19d
Curium strikes up to $8B deal for radiopharma rival Lantheus
fiercebiotech
19d
BioNTech picks Sobi CEO Oelkers to lead as founders plot new mRNA biotech
biospace
19d
STAT+: BioNTech names Guido Oelkers its new CEO
stat
19d
‘Unlikely’ AstraZeneca-BMS mega-merger would be largest pharma deal ever
biospace
19d
BlossomHill eyes $112M IPO harvest to bankroll potential Tagrisso challenger
fiercebiotech
← prev
page 7 of 31
next →
